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Introduction: The essential feature of post-traumatic stress disorder (PTSD) is the development 
of characteristic symptoms following exposure to one or more traumatic events. According to 
evidence-based intervention guidelines and empirical evidence, one of the most extensively 
researched and validated treatments for PTSD is prolonged exposure to traumatic events; how-
ever, exposure therapy can present some limitations. Virtual reality (VR) can help to improve 
prolonged exposure because it creates fictitious, safe, and controllable situations that can enhance 
emotional engagement and acceptance.
Objective: In addition to carrying out a review to evaluate the efficacy of VR exposure-based 
therapy (VR-EBT) for the treatment of PTSD, the aim of this study was to contribute to analyz-
ing the use of VR-EBT by: first, evaluating the adequacy of psychological treatment protocols 
that use VR-EBT to treat PTSD; and second, analyzing the acceptability of VR-EBT.
Method: We performed a replica search with descriptors and databases used in two previous 
reviews and updated to April 2015. Next, we carried out an evaluation of the efficacy, adequacy, 
and acceptability of VR-EBT protocols.
Results: Results showed that VR-EBT was effective in the treatment of PTSD. The findings 
related to adequacy showed that not all studies using VR-EBT reported having followed the 
clinical guidelines for evidence-based interventions in the treatment of PTSD. Regarding 
acceptability, few studies evaluated this subject. However, the findings are very promising, 
and patients reported high acceptability and satisfaction with the inclusion of VR in the treat-
ment of PTSD.
Conclusion: The main weaknesses identified in this review focus on the need for more con-
trolled studies, the need to standardize treatment protocols using VR-EBT, and the need to 
include assessments of acceptability and related variables. Finally, this paper highlights some 
directions and future perspectives for using VR-EBT in PTSD treatment.
Keywords: evidence-based intervention, prolonged exposure, treatment efficacy
Introduction
According to the DSM-5,1 post-traumatic stress disorder (PTSD) involves the 
development of characteristic symptoms, such as distressing memories or dreams about 
the traumatic event, flashbacks, psychological distress produced by internal or external 
cues that symbolize the traumatic event, physiological reactions, avoidance of associ-
ated stimuli, and negative alterations in cognitions and mood. These symptoms appear 
after exposure to one or more traumatic events (eg, exposure to war as a combatant 
or civilian, a physical attack, robbery, mugging, childhood abuse, sexual violence, 
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being kidnapped, a terrorist attack, natural or human-made 
disasters, and motor vehicle accidents). Prevalence in the 
United States is around 8.7%. Rates of PTSD are higher 
among veterans and other people whose vocation increases 
the risk of traumatic exposure (eg, firefighters) and among 
rape survivors. PTSD is more prevalent in females. Several 
studies have found an association between PTSD and low 
quality of life.2
One of the most commonly used evidence-based inter-
ventions for PTSD is prolonged exposure,3–5 which is based 
on emotional processing theory.6 The main components of 
prolonged exposure are in vivo and imaginal exposure to 
stimuli related to the traumatic experience, in addition to 
psycho-education and controlled breathing. In vivo expo-
sure consists of gradually and systematically approaching 
situations that patients avoid. Imaginal exposure involves 
revisiting the memory in the imagination and recounting the 
traumatic event.5,7 Prolonged exposure’s efficacy has been 
demonstrated in several studies,8–15 and has been compared 
to other therapeutic techniques, such as stress inoculation 
training or supportive counseling;16 stress inoculation train-
ing or combined treatment;17 and cognitive restructuring.18 
A recent review concludes that, in general, the addition of 
these techniques does not enhance the efficacy of prolonged 
exposure. This review also points out that, despite all these 
findings, many people with PTSD receive treatments with 
unknown efficacy.5
Prolonged exposure is an efficacious treatment. How-
ever, some people have difficulty imagining the traumatic 
event or emotionally engaging with the memory of the 
traumatic event.5 In addition, some people may find it aver-
sive, given that it involves confronting feared and avoided 
memories.19
Another issue is that exposure therapy appears to be 
under-utilized in clinical practice. Becker et al20 found that, 
although about half of a sample of clinicians reported being 
familiar with imaginal exposure, only 17% used it to treat 
PTSD. One of the main reasons for not using exposure was a 
lack of training and experience with PTSD. When analyzing 
trained clinicians with experience in treating PTSD, less than 
50% used exposure to treat their PTSD patients. The barriers 
reported were concerns about worsening the symptoms or 
increasing the dropout rate. However, these concerns are not 
supported by the scientific evidence.21 In summary, exposure 
therapy seems to have an important dissemination problem 
among clinicians.
Division 12 of the American Psychological Association 
considers prolonged exposure to be a psychological treatment 
with strong empirical support,22,23 which means it is supported 
by two well-designed studies conducted by independent 
investigators.3 Furthermore, according to Division 12 of the 
American Psychological Association, other therapies have 
also shown empirical support, such as present-centered ther-
apy, cognitive processing therapy, seeking safety (for PTSD 
with comorbid substance use disorder), and eye movement 
desensitization and reprocessing. Nevertheless, few studies 
have shown the efficacy of these other therapies.24
Several studies suggest that prolonged exposure has 
been studied more broadly and extensively than other 
therapies,11,12,17,18,24–28 positioning it as the treatment of 
choice. The National Institute for Clinical Excellence also 
recommends the use of prolonged exposure as the treatment 
of choice because it is considered the best-evaluated PTSD 
treatment focusing on exposure.4 Therefore, it is important 
to work on improving the dissemination of prolonged expo-
sure and facilitate its use in people who have difficulties 
imagining the traumatic memory or engaging emotionally, 
in addition to increasing the acceptance of exposure therapy 
by both patients and clinicians. In this regard, technology, 
and specifically virtual reality (VR), can help to advance 
toward this goal.
VR in the treatment of mental 
disorders
VR is a technology that allows the simulation of different 
real-life situations in a tridimensional computer-generated 
environment in which the user can interact with the environ-
ment as if he/she were in the real world. VR has potential as 
an exposure technique for treating different mental disorders 
because VR and real objects have similar characteristics, 
which creates the illusion that the user is immersed and 
engaged with objects in the real world. From a psychological 
point of view, this is a powerful therapeutic tool that helps 
people change their behaviors and protects them while the 
change occurs. VR can help to modify behaviors, thoughts, 
and emotions through virtual experiences designed for and 
adapted to the person’s needs, in order to facilitate and 
enhance the process of change.29 Various studies have dem-
onstrated the efficacy of VR exposure-based therapy (VR-
EBT) for treating different mental disorders. For example, a 
meta-analysis30 compared controlled studies using VR-EBT 
as a stand-alone treatment vs in vivo exposure therapy and a 
control group, for the treatment of anxiety disorders. Results 
showed that in vivo exposure therapy and VR-EBT were 
equally effective. Another meta-analysis31 also supports the 
efficacy of VR-EBT. The authors found that posttreatment 
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results showed similar efficacy to cognitive behavioral 
therapy. VR-EBT shows a powerful real-life impact and good 
stability of the results over time, similar to that of evidence-
based interventions. Other meta-analyses also support VR-
EBT’s efficacy in anxiety disorders.32,33
The main conclusions extracted from the literature 
(on the use of VR-EBT in the treatment of psychological 
disorders34–37) report that its main advantage is the therapist’s 
degree of control over the situations, as he/she can prevent 
the occurrence of unpredictable events or repeat a specific 
exposure task as many times as necessary. Other benefits 
are the ability to expose the patient to stimuli and places 
that would otherwise be difficult to access (eg, a plane), or 
its usefulness in maximizing the benefits of in vivo exposure 
therapy. VR-EBT can be an alternative for people who find 
in vivo exposure therapy aversive. VR-EBT can offer a 
more confidential setting than in vivo exposure therapy (the 
patient’s exposure task takes place within the discreet con-
fines of the therapist’s office). VR is a flexible tool because 
it can replicate different physical or situational environments 
to treat various mental disorders.
In fact, all of these advantages can facilitate the accept-
ability of exposure therapy. A study focused on this issue38 
found that 76% of patients reported being more willing to 
be involved in VR-EBT. In another study conducted to find 
out therapists’ perceptions of the benefits and costs related 
to the use of VR, the therapists reported having knowledge 
about VR and being interested in using it.39
The literature also addresses the limitations of the use of 
VR-EBT in mental health.34–37 Some of the most important 
problems include therapists’ limited accessibility to systems 
based on VR-EBT and lack of training in the use of this tech-
nology. In addition, there is a need for more cross-cultural 
studies to facilitate the generalization of the VR-EBT effects, 
and studies with long-term follow-ups would help to assess 
the maintenance of the results.
VR-EBT in the treatment of PTSD
In the specific case of PTSD, VR-EBT is a promising adjunct 
tool that is an alternative to prolonged exposure (in vivo and 
imagination) and is supported by various studies analyzed in 
recent reviews.40–43 VR can create fictitious, safe, and control-
lable situations that may be more acceptable to participants 
than in vivo exposure. In addition, VR can be an adequate 
alternative for cases where patients have limited ability to 
imagine44 because VR provides the patient with visual and 
auditory stimuli, eliminating the need for intense imaginal 
skills and facilitating immersion in the traumatic event.
Currently, some VR systems already exist for the treat-
ment of PTSD. Since the publication of the first case study 
using VR-EBT to treat this problem in 1999,45 the number 
of studies has increased considerably. In the literature, two 
types of VR environments for the treatment of PTSD are 
clearly identified: 1) a VR environment with very specific and 
realistic situations (eg, Rothbaum et al and other studies45–52); 
and 2) a flexible VR environment that uses symbolism to 
represent any traumatic event.53 The specific and realistic 
VR environments were developed to treat specific traumatic 
events, such as the wars in Vietnam;45 Iraq54 or Baghdad;51 or 
the terrorist attacks of September 11.48 Their main strength 
is their hyperrealism because they recreate the traumatic 
situation with very specific details. Their main weakness is 
that the purpose of these VR environments was to treat the 
traumatic events for which they were developed. As stres-
sors that cause traumatic events can differ (eg, wars, sexual 
assault, terrorist attacks, natural disasters, etc), each traumatic 
event would require a specific VR environment. In terms of 
technological development costs, this would involve a major 
economic investment.55 The other type of VR environment 
is a flexible and adaptable system where any traumatic event 
can be “symbolically” represented using different tools (eg, 
symbols, pictures, music, sounds, video, etc). This VR envi-
ronment could be a good solution for the limitations of VR 
environments that can only be used to treat a specific trau-
matic event.53 This VR environment is the first one reported 
in the literature with these characteristics. Its main strength 
is its flexibility in representing any traumatic event. Its main 
weakness is that for some PTSD populations, a more specific 
and realistic VR environment might be more suitable.
Recently, two reviews examined the efficacy41 and 
methodological quality40 of studies using VR-EBT to treat 
PTSD. The main conclusion of these studies is that VR-EBT 
is as efficacious as traditional exposure therapy. However, 
there is a need for more research that includes well-specified 
randomization procedures, treatment adherence, assessor 
blinding, and intent-to-treat analyses.
The present paper will perform a review to evaluate the 
efficacy of VR-EBT for the treatment of PTSD, but it will 
also address two additional issues in order to contribute to the 
analysis of the use of VR-EBT. First, we will evaluate the ade-
quacy of the treatment protocols that use VR-EBT for PTSD, 
and then we will analyze the acceptability of VR-EBT.
Method
This paper presents a review based on the main findings about 
using VR-EBT in PTSD treatment, including studies that use 
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VR-EBT and compare it to another treatment or a wait-list 
control. Then, we evaluate the adequacy and acceptability 
of the VR-EBT protocols.
Procedure
First, we performed a replica search with the same descrip-
tors and databases used in two previous reviews,40,41 updated 
to April 2015 in the CINAHL, Google Scholar, ISI Web 
of Knowledge, Medline, PsycNET, and Scopus databases. 
Keywords or subjects related to the problem (“post-traumatic 
stress disorder”, “stress disorder”, “PTSD”, “combat 
experience”, “emotional trauma”, “stress reactions”, and 
“trauma”), the intervention (“virtual reality”, “computer 
simulation”, “computer applications”, and “human machine 
systems”), and comparison and outcomes (“treatment”, 
“therapy”, “intervention”, “outcome”, “comparison”, and 
“control group”) were used.
exclusion criteria
The exclusion criteria were: 1) studies published in a non-
peer-reviewed journal, published as conference proceedings, 
or published as a book chapter; 2) studies that evaluated the 
same protocol and/or variables as a previous study, but with-
out providing additional data; 3) VR-EBT was not compared 
to another treatment or a wait-list control; 4) VR was not used 
for treatment or was not specified (eg, assessment, usability 
studies, or 3D systems that were not designed specifically for 
VR-EBT); 5) treatments conducted on web-based systems; 
and 6) theoretical reviews or meta-analyses.
Specifically, the criterion of being published in a peer-
reviewed journal was selected because of the advantages cited 
in the literature:56 it plays a vital role in publishing because 
it allows control over scientific information; it improves the 
quality of a published paper, making it possible to select the 
best papers from journals, facilitating the detection of plagia-
rism. The cited study56 measured the attitudes of researchers 
toward peer review, finding that the peer review process is 
highly regarded by the majority of researchers and considered 
by most to be essential to the communication of research.
inclusion criteria
The inclusion criteria were: 1) studies applying VR-EBT and 
comparing it to another treatment or a wait-list control; and 
2) studies that do not meet any of the exclusion criteria.
With the selected studies, a VR-EBT protocol evaluation 
was carried out based on the evidence-based interventions 
clinical guidelines3,4,57 and evidence-based interventions 
studies5,16 to treat PTSD.
Results
An initial search showed 439 results that responded to the 
initial search criteria. In a first screening, 315 publications 
were excluded because they were published in a non-peer-
reviewed journal, published as conference proceedings, 
or published as a book chapter; or they were duplicates, 
abstracts, conference proceedings, or published in another 
different source. The first screening yielded 124 results, 
identified and distributed as follows: trials or controlled 
studies comparing VR-EBT to another treatment or wait-list 
control, n=20; case studies or case series, n=16; trials with 
only one sample using VR-EBT, n=12; VR was not used in 
the treatment, n=38; treatment conducted on a web-based 
system, n=3; and theoretical reviews or meta-analyses, n=35. 
A second screening excluded 112 papers due to not meeting 
the inclusion criteria or meeting some exclusion criteria (eg, 
studies where there was a previous study that evaluated the 
same protocol).
Finally, 12 studies met the inclusion criteria and were 
included in this review. In addition to the studies analyzed 
in two previous reviews,40,41 we identified four new efficacy 
studies.54,58–60 Figure 1 shows a summary of the study selec-
tion process.
Efficacy of VR-EBT for PTSD
Using vR-eBT to treat military personnel
Most of the studies on the efficacy of VR-EBT were con-
ducted with military personnel who were sent to war zones 
(eg, Vietnam, Iraq, Afghanistan). In an open trial,61 military 
personnel who were sent to the Vietnam war (N=9) were 
enrolled in a VR-EBT (n=5) or a present-centered therapy 
group (n=4). Results showed significant mean improve-
ment (P,0.05) on the Clinician Administered PTSD Scale 
(CAPS)62 at posttreatment and 6-month follow-up, but no 
significant interaction between time and treatment condition. 
In another study,59 participants with PTSD (N=19) were 
randomized to VR-EBT (n=9) or imaginal exposure (n=10) 
treatment and compared to a control group without PTSD 
(n=18); in addition, a functional magnetic resonance imaging 
was conducted. After treatment, VR-EBT reduced CAPS62 
scores (P,0.05), but the imaginal exposure group showed 
no significant changes. Nevertheless, findings showed 
significant change (P,0.05) in both groups on the PTSD 
checklist score; in addition, both groups showed significant 
reductions in amygdala activation after treatment. There were 
no significant changes in the control group.
The efficacy of VR-EBT in active military stationed in 
Iraq and still exposed to a war zone was also studied in a 
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controlled nonrandomized trial (N=10) comparing VR-EBT 
(n=6) to traditional exposure therapy (n=4).63 All partici-
pants showed significant improvements in PTSD symptoms 
(P,0.001), but without finding a significant interaction effect 
(VR-EBT vs traditional). A later randomized clinical trial 
(N=20)64 compared VR-EBT (n=10) to treatment as usual 
(prolonged exposure; cognitive processing therapy; eye 
movement desensitization and reprocessing; group therapy; 
psychiatric medication management; substance rehabilita-
tion; inpatient services; or a combination of these) (n=10). 
The results reported significant improvement (P,0.01), but 
no significant differences between groups. A randomized 
controlled clinical trial (N=22) designed to treat combat- 
related PTSD upon returning from the Iraq war65 compared 
the efficacy of VR-EBT (n=12) to a wait-list control (n=10). 
The results did not show significant differences on the 
CAPS62 measure; but there was a significant decrease in 
criterion C in the VR-EBT group.
Another study developed a VR environment to treat mili-
tary personnel stationed in African colonies. It validated this 
VR environment in a controlled trial (N=10) with three ran-
domized groups: VR-EBT (n=5), imaginal exposure (n=2), 
and wait-list control (n=3). Results showed no significant 
effects, but participants who received VR-EBT showed a 
reduction in symptoms associated with PTSD (depression 
and anxiety).50
Using vR-eBT to treat victims from terrorist attacks
Another population included in the field of VR-EBT con-
sisted of victims of terrorist attacks. One study developed 
a VR environment as a therapeutic tool for victims of 
the September 11 terrorist attacks. This VR environment 
included different situations related to the attacks (eg, people 
jumping from the towers). A clinical trial (N=21) compar-
ing VR-EBT (n=13) to a wait-list control (n=8) showed 
its efficacy.48 PTSD symptoms declined significantly at 
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•&RQIHUHQFHSURFHHGLQJ
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Q 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Figure 1 Summary of studies’ selection process.
Abbreviations: EBT, exposure-based therapy; VR, virtual reality.
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posttreatment (P,0.01), maintaining these levels at the 
6-month follow-up. The findings also revealed that signifi-
cance between groups was also found (P,0.01). This study 
included participants who showed no significant improve-
ment using traditional imaginal exposure, which suggests 
that VR-EBT could be a useful alternative for patients who 
did not benefit from traditional exposure (in vivo or imaginal 
exposure). The authors suggest that the possibility of custom-
izing and adjusting the exposure tasks in VR “may increase 
the patients’ feelings of self-efficacy and of being an active 
agent in their own experience”.
Using vR-eBT to treat victims of criminal violence
VR-EBT has also been administered to victims of criminal 
violence. A VR environment representing some unsafe places 
and situations (eg, assault) in Ciudad Juárez (Mexico) and 
Mexico City was developed and tested as a VR-EBT tool 
for treating people with PTSD caused by criminal violence.59 
Participants (N=20) were randomized to the VR-EBT (n=10) 
or the prolonged exposure (n=10) group. Results showed 
significant improvement on PTSD symptoms, anxiety, and 
depression in both groups (P,0.05); there were no significant 
differences between groups.
Using vR-eBT to treat victims of different traumatic 
events
As mentioned above, there is another type of VR-EBT used in 
the treatment of PTSD. The main difference between this VR 
environment and the realistic VR environment is that it can 
be used to “symbolize” different traumatic events and does 
not require the use of a head-mounted display, making it very 
ergonomic and noninvasive for the patient. This VR envi-
ronment is called “EMMA’s World”. This VR environment 
adapts the contents to the therapeutic needs of each patient 
and can be modified according to the emotional changes that 
occur during the therapeutic process. For a more detailed 
description, see Rey et al.66 The efficacy of this VR-EBT 
for treating PTSD was evaluated in a controlled trial55 with 
victims of different kinds of trauma (motor vehicle accidents, 
mobbing, robbery or assault, and domestic violence) (N=10). 
When comparing VR-EBT to cognitive behavioral therapy, 
symptoms declined significantly after treatment (P,0.05). 
An analysis of the differential efficacy of the two treatments 
showed no significant differences. A later controlled trial67 
confirmed the effectiveness of the VR-EBT in another sample 
(N=16) who had PTSD as a consequence of abuse, crime 
assault, and motor vehicle accidents. The results confirmed 
that VR-EBT (n=8) was as effective as cognitive behavioral 
therapy (n=8). There were no significant differences between 
groups, but an important finding was that other associated 
symptoms (eg, depression or social interference) showed 
statistically significant differences in favor of VR-EBT.
Using vR-eBT and pharmacological treatment
Two recent studies explored the efficacy of combined treat-
ments using VR-EBT and medication to enhance fear extinc-
tion. One of them analyzed efficacy of a treatment using 
VR-EBT and D-cycloserine in a randomized clinical trial.58 
After their exposure to the September 11 terrorist attacks, 
participants (N=25) received 100 mg of D-cycloserine (n=13) 
or a placebo (n=12) 90 minutes before the VR-EBT sessions. 
PTSD remission rates were significantly greater for the VR-
EBT and D-cycloserine group at posttreatment and at the 
6-month follow-up. Another study54 compared the efficacy 
of a combined treatment using VR-EBT and D-cycloserine, 
alprazolam, or placebo. Veterans of the Iraq/Afghanistan war 
(N=156) were given VR-EBT plus 50 mg of D-cycloserine 
(n=53), VR-EBT plus 0.25 mg of alprazolam (n=50), or 
VR-EBT plus placebo (n=53). PTSD symptoms significantly 
improved across all conditions at posttreatment and at the 
3-, 6-, and 12-month follow-ups. There were no differences 
in symptoms between D-cycloserine and placebo. Alprazo-
lam and placebo differed significantly on the CAPS score at 
posttreatment and PTSD diagnosis at 3-month posttreatment; 
the alprazolam group showed a higher rate of PTSD than the 
placebo group.
Adequacy of VR-EBT protocols
Tables 1 and 2 summarize the identified findings, imple-
menting five adequacy variables evaluated in each VR-EBT 
protocol, based on the evidence-based interventions clinical 
guidelines3,4,57 and evidence-based interventions studies (eg, 
Foa et al5,16) to treat PTSD. Table 3 shows the reported com-
ponents of each treatment protocol by session.
Acceptability of vR-eBT protocols
The acceptability of the VR-EBT protocols for the treatment 
of PTSD is an important issue that has not been widely stud-
ied. Very few of the 48 studies reviewed that used VR-EBT 
to treat PTSD reported data about the acceptability of the 
VR-EBT protocols. In this section, we describe the studies 
that explored and reported acceptability.
A trial with a single sample68 assessed clients’ satisfaction 
after a VR-EBT. The results indicated that all participants 
scored 30 or more on a scale ranging from 8 to 32, suggesting 
high levels of satisfaction with VR-EBT.
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Table 2 Adequacy of VR-EBT protocols
Adequacy variable Description Result
1. Treatment of choice The use of prolonged exposure (with 
in vivo and imaginal exposure), psycho-
education, and breathing training; it was 
considered the treatment with a strong 
research support, and studied more broadly 
and extensively than other therapies.
Six studies55,59,60,63,64,67 reported the use of prolonged 
exposure.
2. Number of sessions A range from 8 to 12 is recommended. Total sessions ranged from 3 to 20; six studies55,58,60,61,65,67 
ranged from 8 to 12 sessions; three studies59,63,64 reported 
that their protocol had a duration of 3 to 20 sessions.
3. Treatment session 
length
90 minutes is recommended. Six studies54,55,58–61 reported a length of 90 minutes.
4. Periodicity Once a week is recommended. Seven studies48,54,55,58,63,64,67 reported a weekly treatment 
periodicity.
5. (a) Number of sessions 
of vR-eBT and (b) 
the vR display and 
additional stimuli used 
were also addressed
it is not determined. (a) The vR-eBT range of sessions is between 3 and 20.
(b) Nine studies48,50,54,58–60,63–65 used a head-mounted display, 
two studies55,67 used a large projection screen, and one 
study61 did not report this information.
Abbreviations: VR, virtual reality; VR-EBT, VR exposure-based therapy.
Baños et al53 also explored the acceptability of VR-EBT. 
They asked participants about their expectations and satisfac-
tion with treatment. Before treatment, the mean scores ranged 
from 7 to 8 (on a 0–10 scale) with regard to the logicality, 
satisfaction, or the utility of VR-EBT. In addition, partici-
pants rated aversiveness from 4 to 6. After treatment, the 
satisfaction means increased compared to the expectation, 
as participants evaluated their satisfaction with VR-EBT 
program higher than they did initially, and they rated the 
treatment as less aversive.
Another study69 with veterans of the Iraq war evaluated 
their acceptance in using VR-EBT for mental health. A sur-
vey showed that 83% of the participants reported that they 
were neutral-to-very-willing to use some technology as part 
of a treatment; 71% were equally willing or more willing to 
use a treatment based on technology than to merely talk to 
a therapist in a traditional treatment.
De la Rosa and Cárdenas-López60 explored differences in 
the level of satisfaction with the treatment between a group 
that received VR-EBT and another one that received imaginal 
exposure. The results showed no differences in the groups’ 
satisfaction. This result coincides with another study70 that 
found no differences in satisfaction between the VR-EBT 
group and the imaginal exposure group. The participants 
evaluated both treatments as useful, and they would recom-
mend them to a friend or family member who had PTSD. 
They also reported significant differences in the degree of 
aversion. The authors state that these findings are consistent 
with other studies using VR-EBT for specific phobias, where 
participants found it easier to take the first step to confront 
their fears in VR environments.38
Other studies that used VR-EBT for PTSD reported 
only qualitative or opinion data; for example, a case study71 
reported that the participant said he felt comfortable with 
the technology and found the treatment to be logical and 
credible. In another case study,72 when the patient was 
asked his opinion of the role of VR in his improvement, 
he stated “I don’t think I would be where I am today 
without it”.
Conclusion
Currently, we have the possibility of applying VR-EBT for 
the treatment of PTSD. The literature review indicates that 
VR-EBT is an effective and promising alternative for the 
treatment of PTSD. Research reveals that VR-EBT is as effi-
cacious as traditional treatments (imaginal exposure, in vivo 
exposure therapy, cognitive behavioral therapy, treatment as 
usual, and present-centered therapy). Furthermore, VR-EBT 
offers other advantages that could play an important role, 
for example, in reducing aversion to prolonged exposure,70 
treatment dropout, and generalization of the results to other 
symptom groups,67 as well as long-term maintenance of the 
results.61,64,73 VR-EBT for the treatment of PTSD has shown 
a significant reduction in symptoms related to the traumatic 
event. Studies have focused mainly on war veterans, show-
ing significant changes at posttreatment and follow-ups. The 
results from most of the studies are quite promising, showing 
that VR-EBT is useful for those suffering from acute or early 
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chronic combat PTSD. The findings also highlight that this 
treatment could be generalized to a wide range of symptoms 
and situations, with the greatest likelihood of long-term 
benefits.43 It is also important to note that controlled studies 
are still scarce. It is necessary to conduct more controlled 
trials with larger and more representative samples from dif-
ferent cultures in order to draw firmer conclusions about the 
effectiveness of VR-EBT in treating PTSD. We are likely to 
have additional data soon, given that a recent search found 
13 trials registered on www.clinicaltrials.gov that specified 
the use of VR-EBT with or without other interventions 
(prolonged exposure, treatment as usual, drug, augmented 
exposure therapy, wait-list control) for treating PTSD; three 
of them were registered in the last 2 years.
Another relevant aspect is the use of VR from a preven-
tion perspective. A study conducted with children in an 
earthquake-vulnerable area explored the possibilities of 
using VR to improve coping strategies to face future trau-
matic events.74 The results supported the hypothesis that 
pre-disaster VR programs can increase resilience in children. 
However, there is a lack of applications for VR-EBT aimed 
at the population of children. The literature only contains 
one reported case study75 about the treatment of PTSD in 
children, which reveals a great need in this field, consider-
ing the problems of abuse, violence, or natural disasters 
that children are exposed to around the world. Furthermore, 
recently, researchers are studying VR’s potential in improv-
ing coping strategies and delivering stress resilience training 
in the military prior to traveling to war zones.76 Some authors 
highlight this potential use of VR43 as an emerging field of 
interest in mental health because it can prepare vulnerable 
populations for potential stressful and traumatic events.
The findings related to the adequacy of VR-EBT protocols 
showed that not all studies specified and reported that they 
followed the guidelines for evidence-based interventions in 
the treatment of PTSD. Most of them used VR-EBT alone or 
in combination with other therapeutic techniques, but there 
was no detailed report of all the features required by the 
clinical guidelines.3 Therefore, it is important to standardize 
treatment protocols for using VR-EBT in PTSD treatment, 
with an emphasis on treatment adherence.
Regarding its acceptability, one of the most frequently 
cited advantages of VR-EBT is that it would be more easily 
accepted than other forms of exposure (in vivo or imagi-
nal). In fact, this has been explored and demonstrated by 
some studies in the field of anxiety disorders (eg, in specific 
phobia38). However, and surprisingly, the field of PTSD 
treatment has not adequately addressed this question. One 
important finding of this review is that most of the studies 
did not include or report an assessment of acceptability. 
Few studies have evaluated this issue. The findings are very 
promising, as patients reported high satisfaction and accept-
ability about the inclusion of VR in PTSD treatment. Given 
that one of the limitations of exposure therapy for PTSD 
may be a lack of acceptance by patients and clinicians;20 it is 
important for studies to include an analysis of acceptability 
when exploring the utility of VR-EBT.
Another challenge is to provide training for mental health 
providers in the use of VR-EBT. This involves incorporat-
ing specific training in master programs. To date, very few 
universities or academic centers offer any specific training in 
the field of cyberpsychology or e-health. One study analyzed 
mental health clinicians’ perceptions of using VR-EBT to 
conduct PTSD treatment in veterans.77 The study reported that 
the use of VR-EBT is feasible and acceptable to clinicians; 
its main conclusions suggest that they perceive VR-EBT as 
a step forward in treatment. It would be very acceptable to 
veterans. These results are promising, but it would be desir-
able to explore this important issue in further studies.
The big challenge is to bring these findings to the 3.6% 
of the world’s population that, according to the World Health 
Organization, has suffered from PTSD. A recent cross-na-
tional survey in 21 countries78 pointed out that more than 10% 
of participants reported witnessing violence (21.8%) or expe-
riencing interpersonal violence (18.8%), accidents (17.7%), 
exposure to war (16.2%), or trauma to a loved one (12.5%). 
These data reveal that it is important to conduct studies 
related to the use of VR-EBT for the treatment of PTSD. In 
this sense, various research groups studying the efficacy of 
VR-EBT in the treatment of PTSD are making great efforts to 
bring these treatments to mental health providers and patients 
in different parts of the world, for example, the United 
States (www.vrphobia.com, www.virtuallybetter.com), 
Spain (www.labpsitec.es, www.previsl.com), Belgium 
(www.vrphobia.eu), Mexico (www.solucionesvirtuales.com.mx), 
and Canada (w3.uqo.ca/cyberpsy, invirtuo.com).
Finally, it is necessary to interpret the results and conclu-
sions of this review with caution because of some limita-
tions. This review refers to a limited number of studies that 
met the inclusion criteria, which limits the type of studies 
reviewed to peer-reviewed studies. We made this decision 
in order to include studies with the highest quality possible; 
however, we recognize that, following these criteria, studies 
with nonsignificant results could be underreported. Future 
reviews should consider these aspects.
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